Top 4 Most Richly Funded Exosome Startups
To date, four companies have dominated the exosome funding world. These companies are:
-
Codiak Biosciences
-
Exosome Diagnostics
-
Evox Therapeutics
-
ExoCoBio Inc.
ExoCoBio is a venture-backed startup that develops exosome-based cosmeceuticals and biopharmaceuticals for skin and tissue regeneration. It was established in January 2017 to develop innovative biopharmaceuticals and cosmeceuticals based on stem cell-derived exosomes.
In total, exosome start-up companies have received approximately $388.2 million in investor funding, as shown below. VivaZome’s contribution is not included, because it was secured as a government grant.
-
Codiak Biosciences – $168.5 Million
-
Exosome Diagnostics – $112 Million
-
Evox Therapeutics – $59.5 Million
-
ExoCoBio Inc. – $46 Million
TOTAL = $386.2 MILLION
Source: BioInformant